ArticleCancer immunology, immunotherapy : CII2026

Pilot report of an anti-PD-1/VEGF bispecific antibody for treating recurrent H3K27M-mutant diffuse midline gliomas.

Li Yanchu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.